vs

Side-by-side financial comparison of Terra Property Trust, Inc. (TPTA) and Verastem, Inc. (VSTM). Click either name above to swap in a different company.

Verastem, Inc. is the larger business by last-quarter revenue ($11.2M vs $7.1M, roughly 1.6× Terra Property Trust, Inc.). Terra Property Trust, Inc. runs the higher net margin — -150.2% vs -876.3%, a 726.1% gap on every dollar of revenue.

The National Savings and Trust Company is a historic bank building located at the corner of New York Avenue and 15th Street, NW in Downtown Washington, D.C. It has also been known as the National Safe Deposit Company and the National Safe Deposit Savings and Trust Company.

Verastem, Inc., doing business as Verastem Oncology, is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index.

TPTA vs VSTM — Head-to-Head

Bigger by revenue
VSTM
VSTM
1.6× larger
VSTM
$11.2M
$7.1M
TPTA
Higher net margin
TPTA
TPTA
726.1% more per $
TPTA
-150.2%
-876.3%
VSTM

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
TPTA
TPTA
VSTM
VSTM
Revenue
$7.1M
$11.2M
Net Profit
$-10.6M
$-98.5M
Gross Margin
Operating Margin
-48.8%
-362.2%
Net Margin
-150.2%
-876.3%
Revenue YoY
-37.4%
Net Profit YoY
32.0%
-311.1%
EPS (diluted)
$-0.43
$-1.35

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
TPTA
TPTA
VSTM
VSTM
Q4 25
$7.1M
Q3 25
$7.3M
$11.2M
Q2 25
$8.6M
$2.1M
Q1 25
$12.5M
Q4 24
$11.3M
Q3 24
$12.2M
$0
Q2 24
$11.2M
$10.0M
Q1 24
$15.0M
Net Profit
TPTA
TPTA
VSTM
VSTM
Q4 25
$-10.6M
Q3 25
$-6.7M
$-98.5M
Q2 25
$-9.2M
$-25.9M
Q1 25
$-1.3M
Q4 24
$-15.6M
Q3 24
$-7.8M
$-24.0M
Q2 24
$-7.5M
$-8.3M
Q1 24
$-6.2M
Operating Margin
TPTA
TPTA
VSTM
VSTM
Q4 25
-48.8%
Q3 25
6.7%
-362.2%
Q2 25
-28.4%
-2047.9%
Q1 25
32.8%
Q4 24
-72.3%
Q3 24
54.1%
Q2 24
6.3%
-182.8%
Q1 24
32.0%
Net Margin
TPTA
TPTA
VSTM
VSTM
Q4 25
-150.2%
Q3 25
-92.4%
-876.3%
Q2 25
-106.5%
-1213.6%
Q1 25
-10.3%
Q4 24
-138.3%
Q3 24
-63.9%
Q2 24
-67.5%
-82.6%
Q1 24
-41.2%
EPS (diluted)
TPTA
TPTA
VSTM
VSTM
Q4 25
$-0.43
Q3 25
$-0.28
$-1.35
Q2 25
$-0.38
$-0.62
Q1 25
$-0.05
Q4 24
$-0.65
Q3 24
$-0.32
$-0.60
Q2 24
$-0.31
$-0.31
Q1 24
$-0.25

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
TPTA
TPTA
VSTM
VSTM
Cash + ST InvestmentsLiquidity on hand
$33.2M
$137.7M
Total DebtLower is stronger
$178.9M
Stockholders' EquityBook value
$146.5M
$-15.5M
Total Assets
$351.5M
$176.9M
Debt / EquityLower = less leverage
1.22×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
TPTA
TPTA
VSTM
VSTM
Q4 25
$33.2M
Q3 25
$17.4M
$137.7M
Q2 25
$5.9M
$164.3M
Q1 25
$11.9M
Q4 24
$8.6M
Q3 24
$21.2M
$113.2M
Q2 24
$18.9M
$83.4M
Q1 24
$17.9M
Total Debt
TPTA
TPTA
VSTM
VSTM
Q4 25
$178.9M
Q3 25
$211.9M
Q2 25
$260.2M
Q1 25
$286.7M
Q4 24
$326.1M
Q3 24
$312.9M
$40.5M
Q2 24
$383.8M
$40.3M
Q1 24
$377.6M
Stockholders' Equity
TPTA
TPTA
VSTM
VSTM
Q4 25
$146.5M
Q3 25
$159.7M
$-15.5M
Q2 25
$168.5M
$36.1M
Q1 25
$179.9M
Q4 24
$185.7M
Q3 24
$206.2M
$11.1M
Q2 24
$218.6M
$18.9M
Q1 24
$230.5M
Total Assets
TPTA
TPTA
VSTM
VSTM
Q4 25
$351.5M
Q3 25
$398.1M
$176.9M
Q2 25
$459.3M
$196.3M
Q1 25
$495.2M
Q4 24
$542.8M
Q3 24
$546.8M
$126.4M
Q2 24
$634.4M
$105.7M
Q1 24
$640.2M
Debt / Equity
TPTA
TPTA
VSTM
VSTM
Q4 25
1.22×
Q3 25
1.33×
Q2 25
1.54×
Q1 25
1.59×
Q4 24
1.76×
Q3 24
1.52×
3.66×
Q2 24
1.76×
2.14×
Q1 24
1.64×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
TPTA
TPTA
VSTM
VSTM
Operating Cash FlowLast quarter
$1.9M
$-36.2M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
TPTA
TPTA
VSTM
VSTM
Q4 25
$1.9M
Q3 25
$-4.3M
$-36.2M
Q2 25
$1.2M
$-32.7M
Q1 25
$861.6K
Q4 24
$-3.3M
Q3 24
$1.7M
$-23.8M
Q2 24
$-3.1M
$-27.6M
Q1 24
$-4.2M
Free Cash Flow
TPTA
TPTA
VSTM
VSTM
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
$-27.6M
Q1 24
FCF Margin
TPTA
TPTA
VSTM
VSTM
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
-275.8%
Q1 24
Capex Intensity
TPTA
TPTA
VSTM
VSTM
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.0%
Q3 24
Q2 24
0.1%
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons